These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28829805)

  • 1. Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.
    Pellegrini C; Orlandi A; Costanza G; Di Stefani A; Piccioni A; Di Cesare A; Chiricozzi A; Ferlosio A; Peris K; Fargnoli MC
    PLoS One; 2017; 12(8):e0183415. PubMed ID: 28829805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
    Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
    PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
    Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Digiovanni J; Sano S
    Mol Carcinog; 2013 Oct; 52(10):760-9. PubMed ID: 22431065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
    Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
    Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
    Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
    Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
    Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
    J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
    De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
    Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
    Berman B; Sullivan T; De Araujo T; Nadji M
    Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine mRNA expression in basal cell carcinoma.
    Gambichler T; Skrygan M; Hyun J; Bechara F; Tomi NS; Altmeyer P; Kreuter A
    Arch Dermatol Res; 2006 Aug; 298(3):139-41. PubMed ID: 16826314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo.
    Urosevic M; Maier T; Benninghoff B; Slade H; Burg G; Dummer R
    Arch Dermatol; 2003 Oct; 139(10):1325-32. PubMed ID: 14568837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
    Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
    Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial.
    Peris K; Campione E; Micantonio T; Marulli GC; Fargnoli MC; Chimenti S
    Dermatol Surg; 2005 Mar; 31(3):318-23. PubMed ID: 15841634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
    Schiessl C; Wolber C; Tauber M; Offner F; Strohal R
    J Drugs Dermatol; 2007 May; 6(5):507-13. PubMed ID: 17679185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
    Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
    Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.
    Venturini M; Sala R; Gonzàlez S; Calzavara-Pinton PG
    Br J Dermatol; 2013 Jan; 168(1):99-105. PubMed ID: 23013443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.